The FSCP has issued a written direction to a financial adviser that recommended three clients switch their super and invest in a product “associated with the relevant provider”.
There have been a raft of Financial Services and Credit Panel (FSCP) decisions related to superannuation over the last few months, however these have largely been confined to contribution errors resulting in tax bills for clients.
In its latest decision, however, the FSCP found that a financial adviser recommended clients switch their superannuation and invest in an inappropriate financial product.
While the adviser is anonymised as ‘Mr V’, the FSCP said he was the sole director of a company that holds an Australian Financial Services licence and is the responsible manager and key person under that licence.
“The relevant provider recommended in a Statement of Advice presented to Client A on 8 February 2022, Client B on 18 February 2022 and Client C on 30 March 2023 that each client switch their existing superannuation into a new product and invest part of it in a financial product associated with the relevant provider,” the panel said.
“The Sitting Panel determined that in giving that advice, the relevant provider contravened s961G of the Corporations Act 2001 by giving advice that was not appropriate, and s961J(1) of the Corporations Act 2001 by prioritising the relevant provider’s interests over the clients’ interests.”
It also found that Mr V contravened s921E(3) of the Corporations Act 2001 by failing to comply with the Code of Ethics – specifically noting and Standards 3, 7 and 9.
“The Sitting Panel’s finding in relation to Standard 3 was that advice was given where the relevant provider had a conflict of interest,” the FSCP said.
“In relation to the Standard 7, the Sitting Panel made two findings: one, that the relevant provider did not obtain the clients’ free, prior and informed consent to all relevant remuneration arrangements by failing to disclose the benefits that the relevant provider and their associates would receive as a result of the clients’ investment in the recommended financial product; and two, that the relevant provider failed to ensure that their fees and charges were fair and reasonable and represented value for money by charging the clients extraordinary fees for advice that was not appropriate and conflicted.
“The Sitting Panel’s finding in relation to Standard 9 was that the relevant provider made a recommendation that was not in good faith because the recommended financial product was performing poorly and expensive, and therefore was not an appropriate investment for the clients.”
In response to the contraventions, the FSCP issued a written direction to the relevant provider requiring the relevant provider to report to ASIC on a range of specified matters by 31 October 2025:
Never miss the stories that impact the industry.